Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia
British Journal of Haematology (2017)
  • Tadeusz Robak, Medical University of Łódź
  • Andrzej Hellmann, Gdańsk Medical University
  • Janusz Kloczko, Medical University of Białystok
  • Javier Loscertales, Harvard University
  • Ewa Lech-Maranda, Medical University of Łódź
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Anthony Mato, University of Pennsylvania
  • John C. Byrd, Ohio State University
  • Farrukh T. Awan, Ohio State University
  • Holger Hebart, University of Tübingen
  • Jose A. Garcia-Marco, University of California, Irvine
  • Brian T. Hill, Cancer Institute
  • Michael Hallek, University of Cologne
  • Amy J. Eisenfeld
  • Scott C. Stromatt
  • Ulrich Jaeger, Medical University of Vienna
Link
Disciplines
Publication Date
January 2, 2017
DOI
10.1111/bjh.14464
Citation Information
Tadeusz Robak, Andrzej Hellmann, Janusz Kloczko, Javier Loscertales, et al.. "Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia" British Journal of Haematology Vol. 176 Iss. 4 (2017) p. 618 - 628
Available at: http://works.bepress.com/john-pagel/29/